TNF Pharmaceuticals announces improved financial position

TNF Pharmaceuticals (TNFA) announced that is has significantly improved its financial position over the past 5 months through a material reduction in liabilities, while maintaining total assets of over $17M as of June 30. “The recent significant improvement in our financial position gives TNF a stronger platform for growth opportunities and taking advantage of shareholder value creation opportunities,” said TNF President and CMO, Mitchell Glass. The improvements in the Company’s financial position will be reflected in future financial statements of the Company.